Saltar al contenido
Merck

Concise Chemoenzymatic Total Synthesis and Identification of Cellular Targets of Cepafungin I.

Cell chemical biology (2020-08-09)
Alexander Amatuni, Anton Shuster, Alexander Adibekian, Hans Renata
RESUMEN

The natural product cepafungin I was recently reported to be one of the most potent covalent inhibitors of the 20S proteasome core particle through a series of in vitro activity assays. Here, we report a short chemoenzymatic total synthesis of cepafungin I featuring the use of a regioselective enzymatic oxidation to prepare a key hydroxylated amino acid building block in a scalable fashion. The strategy developed herein enabled access to a chemoproteomic probe, which in turn revealed the exceptional selectivity and potency of cepafungin I toward the β2 and β5 subunits of the proteasome. Further structure-activity relationship studies suggest the key role of the hydroxyl group in the macrocycle and the identity of the lipid tail in modulating the potency of this natural product family. This study lays the groundwork for further medicinal chemistry exploration to fully realize the anticancer potential of cepafungin I.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Penicilina- Estreptomicina, Solution stabilized, with 10,000 units penicillin and 10 mg streptomycin/mL, 0.1 μm filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Disolución de aminoácidos no esenciales MEM (x100), without L-glutamine, liquid, sterile-filtered, BioReagent, suitable for cell culture
Sigma-Aldrich
Yodoacetamida, BioUltra
Sigma-Aldrich
Tris[(1-benzyl-1H-1, 2, 3-triazol-4-yl)methyl]amine, 97%
Sigma-Aldrich
Azide-PEG3-biotin conjugate
Sigma-Aldrich
N-Succinyl-Leu-Leu-Val-Tyr-7-Amido-4-Methylcoumarin, ≥90% (HPLC)